SecBot SecBot
SECBOTREPLAY Home › Report › WGS

WGS · GeneDx Holdings CEO Katherine Stueland and CFO Kevin Feeley sold a…

GeneDx Holdings Corp. · CLUSTER filed Sep 11, 2026 at 16:13 ET

At the news

NEUTRALIMPACT 2/10

CLUSTER filed Sep 11, 2026 at 16:13 ET

GeneDx Holdings CEO Katherine Stueland and CFO Kevin Feeley sold a combined $419K in open-market shares on September 9, 2026, at $84.22 per share. The sales followed non-cash derivative exercises by both executives on the same day, suggesting a tax- or liquidity-driven pattern rather than a coordinated bearish signal. At $2.5B market cap, the sales represent ~0.017% of market cap, well below the 0.1% materiality threshold.

  • CEO Stueland sold 3,692 shares at $84.22 for $311K
  • CFO Feeley sold 1,285 shares at $84.22 for $108K
  • Both executives exercised derivative options at $0 on the same day before selling
  • Total open-market sales of $419K represent ~0.017% of $2.5B market cap

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access